期刊文献+

阿托伐他汀治疗原发性肾病综合征的效果观察 被引量:3

Research on effect of atorvastatin treatment for primary nephrotic syndrome
下载PDF
导出
摘要 目的 探讨阿托伐他汀治疗原发性肾病综合征的临床效果。方法 选取本院2010年1月1日~2013年12月31日收治的52例原发性肾病综合征患者为研究对象,将其随机分为对照组和实验组,两组患者均接受常规药物治疗,实验组在此基础上接受阿托伐他汀治疗,分析比较两组患者的临床治疗效果。结果 实验组的总有效率为100.00%,对照组为80.77%,两组比较差异有统计学意义(P〈0.05);实验组临床治疗后相关指标明显优于对照组(P〈0.05)。结论 阿托伐他汀治疗原发性肾病综合征具有较为理想的临床效果,有助于患者临床指标的恢复.值得推广和府用. Objective To investigate the clinical effect of atorvastatin in treatment of primary nephrotic syndrome. Methods 52 patients with primary nephrotic syndrome were selected in our hospital from January 1,2010 to December 31,2013 primary nephrotic syndrome patients as the research object,and they were randomly divided into experimental group and control group,two patients were received conventional drug treatment,the experimental group was received atorvastatin treatment on the basis of this,the clinical therapeutic effect of two groups were analyzed and compared. Results The total effective rate in the experimental group was 100.00%,the control group was 80.77%, the difference was statistically significant between the two groups (P〈0.05).The contrast index related to clinical treatment of patients in the experimental group were significantly better than the control group (P〈0.05). Conclusion Atorvastatin treatment for primary nephrotic syndrome has ideal clinical effect,is helpful to the recovery of patients clinical indicators,it is worthy of popularization and application.
作者 王海峰
出处 《中国当代医药》 2014年第13期48-50,共3页 China Modern Medicine
关键词 阿托伐他汀 原发性肾病综合征 临床效果 Atorvastatin Primary nephrotic syndrome Clinical effect
  • 相关文献

参考文献12

二级参考文献49

共引文献34

同被引文献34

  • 1王海燕,郑法雷,刘玉春,等.原发性肾小球疾病分型与治疗及诊断标准专题座谈会纪要[J].中华内科杂志,1993,32(2):131-134.
  • 2Ismail-Beigi F,Craven T,Banerji MA,et al.Effect of in-tensive treatment of hyperglyeaemia on mierovascular out-come in type 2 diabetes;all analysis of the ACCORD ran-domised trail[J].Lancet, 2010,376(9739):419-430.
  • 3Molfino A,Don BR,Kaysen GA.Chapter 26-Nutritional and Nonnutritional Management of the Nephrotic Syndrome[J].Nutritional Management of Renal Disease,2013,6(5):393-413.
  • 4Adu EM.Serum lipid profile abnormalities among patients with nephrotic syndrome[J].International Journal of Medicine and Biomedical Research,2013,2(1):13-17.
  • 5Sripriyalakshmi S,Anjali CH,George PDC,et al.BSA nanoparticle loaded atorvastatin calcium-a new facet for an old drug[J].Plos One,2014,9(2):e86317.
  • 6Peruzzi M,De L,Thomsen HS,et al.A Network Meta-Analysis on Randomized Trials Focusing on the Preventive Effect of Statins on Contrast-Induced Nephropathy[J].Biomed Res Int,2014;2014:213239.doi:10.1155/2014/213239.Epub 2014 Sep 7.
  • 7Akiko Takazakura,Masaru Sakurai,Yukihiro Bando,et al.Renoprotective effects of atorvastatin compared with pravastatin on progression of early diabetic nephropathy[J].Journal of Diabetes Investigation,2015,6(3):346-353.
  • 8张玉环,郑璇,秦双双,等.阿伐他汀钙联合低分子肝素治疗78例肾病综合征的疗效观察[J].四川医学,2013,34(10):1562-1564.
  • 9李云辉.阿托伐他汀联合厄贝沙坦治疗糖尿病肾病疗效观察[J].医学临床研究,2008,25(6):1000-1001. 被引量:3
  • 10徐延敏,李广平.他汀类药物在心脑血管疾病防治中的临床循证医学证据[J].中国现代神经疾病杂志,2009,9(1):26-30. 被引量:10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部